Fresenius Medical Care Wins Major Award for Supporting U.S. Veterans with Industry-Leading Dialysis Care

Department of Veterans Affairs approves purchase of FMCNA products in five categories

WALTHAM, Mass., August 30, 2022 /PRNewswire/ — Fresenius Medical North America (FMCNA) Renal Therapies Group, the leading provider of kidney care products, will be the company of choice to help treat more than 35,000 military veterans receiving dialysis from the US Department of Veterans Affairs (VA). The VA awarded a five-year contract to FMCNA in five different categories, most of any medical device company, including home dialysis machines, critical care equipment, water purification systems and l center hemodialysis.

“We are extremely proud to continue our decades-long relationship with Veterans Affairs and to serve the men and women who have given so much for their country,” said Joe Turkish, President of the Renal Therapy Group at Fresenius Medical Care North America. “This contract is a testament to our innovation, our cutting-edge technology and our ability to meet the needs of our veterans, whether they require in-hospital, outpatient and, increasingly, home dialysis.

Under the five-year nationwide contract, all 106 VA hospitals and clinics can purchase Fresenius Medical Care’s comprehensive center, acute, and home dialysis offerings. This VA commitment allows our veterans access to continuity of care through the industry’s leading provider.

VA approval includes industry leader BlueStar 2008T hemodialysis machine which provides life-saving dialysis care with the addition of the industry’s only integrated fluid management technology. The contract also includes the NxStage® System One S™ with NxView for hospital systems to provide continuous renal replacement therapy (CRRT) to patients with acute renal failure, as well as The AquaC UNO Ha portable, space-saving water treatment system.

Two home dialysis systems from Fresenius Medical Care has also received this VA approval, including the NxStage versionHD and Freedom® Select Cycler. Enabling more patients to choose home dialysis is a key priority for business and government, as it can provide veterans with greater flexibility and independence in their lifestyle.

“Fresenius Medical Care has been a leader in dialysis services for many decades,” said Dr. Mink Chawla, former Chief of Critical Care at the washington d.c., VA Medical Center. “Our veterans deserve the best care, and I’m thrilled they have access to Fresenius Medical Care’s state-of-the-art devices and services.”

The contract takes effect from August 1, 2022through July 31, 2027.

About Fresenius Medical Care North America

Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care for people with kidney disease and other chronic conditions. Through its industry-leading network of dialysis facilities and ambulatory cardiac and vascular laboratories, Fresenius Medical Care North America provides coordinated health care services at essential points of care for hundreds of thousands of customers. chronically ill across the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposables and renal pharmaceuticals. For more information, visit the Fresenius Medical Care North America website at https://fmcna.com/.

Media Contact:

Fresenius medical care
Scott Sayres
Business communication
[email protected]
+1 (940) 297-5678

SOURCE Fresenius Medical Care Holdings, Inc.